Related Experiment Video

Updated: Jan 14, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K

Rethinking Cancer Drug Development through Tumor-agnostic Precision Medicine

Vivek Subbiah1

  • 1Sarah Cannon Research Institute, Nashville, Tennessee.

Cancer Discovery
|October 17, 2025
PubMed

Insights

Tumor-agnostic therapies shift cancer treatment from location to molecular drivers. Accelerating drug development aims to provide equitable, personalized molecular therapies for all patients within 25 years.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Traditional cancer treatment relies on anatomic tumor classification.
  • This approach can lead to therapeutic inequities based on tumor location.
  • Molecular-driven cancer treatment offers a personalized alternative.

Purpose of the Study:

  • To advocate for a paradigm shift in cancer therapy from anatomic to molecular classification.
  • To highlight the potential of tumor-agnostic therapies in improving patient outcomes.
  • To call for accelerated development of tissue-agnostic drugs.

Main Methods:

  • Review of current cancer treatment paradigms.
  • Analysis of the impact of molecular profiling on therapeutic decisions.
  • Projection of future drug development needs for tumor-agnostic treatments.

Main Results:

  • Tumor-agnostic therapies represent a significant advancement over traditional methods.
  • Current drug approvals are limited (10), but the potential exists for 50-100 within 25 years.
  • Personalized molecular treatment can eliminate therapeutic inequities.

Conclusions:

  • A transition to molecular-driven cancer treatment is essential.
  • Accelerated development of tumor-agnostic therapies is crucial.
  • Ensuring patients receive therapy based on molecular identity, not anatomic location, is the goal.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.3K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K